We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
-9.36%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$1.32B
AUM Growth
+$149M
Cap. Flow
+$284M
Cap. Flow %
21.5%
Top 10 Hldgs %
49.58%
Holding
259
New
20
Increased
70
Reduced
100
Closed
34

Sector Composition

Rank Sector Weight
1 Financials 4.11%
2 Technology 2.36%
3 Communication Services 1.74%
4 Healthcare 1.38%
5 Consumer Staples 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
76
TJX Companies
TJX
$171B
$2.28M 0.17%
50,976
-1,872
-4% -$94.6K
AMJ
77
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$2.14M 0.16%
95,965
+72,670
+312% +$1.84M
BSV icon
78
Vanguard Short-Term Bond ETF
BSV
$44.7B
$2.12M 0.16%
27,023
+6,620
+32% +$516K
WFC icon
79
Wells Fargo
WFC
$265B
$2.06M 0.16%
44,583
+973
+2% +$49.8K
SCHW
80
Charles Schwab
SCHW
$177B
$2.03M 0.15%
48,992
-1,953
-4% -$88.3K
RTN
81
DELISTED
Raytheon Company
RTN
$1.84M 0.14%
11,943
-1,936
-14% -$347K
VZ icon
82
Verizon
VZ
$182B
$1.79M 0.14%
31,812
-3,240
-9% -$184K
IWN icon
83
iShares Russell 2000 Value ETF
IWN
$14.4B
$1.74M 0.13%
16,202
+4,519
+39% +$544K
SCHE icon
84
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
$1.73M 0.13%
73,367
+2,797
+4% +$67.8K
MMM icon
85
3M
MMM
$83.4B
$1.67M 0.13%
10,514
-1,048
-9% -$174K
DHR icon
86
Danaher
DHR
$144B
$1.59M 0.12%
17,449
-2,508
-13% -$228K
CMCSA icon
87
Comcast
CMCSA
$85B
$1.58M 0.12%
46,540
-3,269
-7% -$119K
IGSB icon
88
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$1.56M 0.12%
30,261
-798
-3% -$41.1K
HYG icon
89
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$1.53M 0.12%
18,858
+10,313
+121% +$863K
NEE icon
90
NextEra Energy
NEE
$185B
$1.51M 0.11%
34,680
-1,196
-3% -$52.3K
TOTL icon
91
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.15B
$1.5M 0.11%
31,637
-9,600
-23% -$451K
MRK icon
92
Merck
MRK
$315B
$1.49M 0.11%
20,488
-1,119
-5% -$79K
XOM icon
93
ExxonMobil
XOM
$611B
$1.47M 0.11%
21,589
-1,624
-7% -$127K
MDY icon
94
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$1.47M 0.11%
4,850
+27
+0.6% +$8.99K
QCOM icon
95
Qualcomm
QCOM
$181B
$1.44M 0.11%
25,203
-5,502
-18% -$334K
PFE icon
96
Pfizer
PFE
$143B
$1.26M 0.1%
30,373
-529
-2% -$22K
SCZ icon
97
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.9B
$1.22M 0.09%
+23,553
New +$1.32M
QEMM icon
98
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$53.4M
$1.18M 0.09%
21,744
INTC icon
99
Intel
INTC
$478B
$1.16M 0.09%
24,776
-1,293
-5% -$60.5K
IWF icon
100
iShares Russell 1000 Growth ETF
IWF
$123B
$1.1M 0.08%
33,580
-6,420
-16% -$226K

Similar funds

Aspiriant LLC's Q4 2018 Portfolio in Review

As of Q4 2018, Aspiriant LLC held 259 positions worth $1.32B, up 13% from $1.17B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Aspiriant LLC deployed $284M of net new capital in Q4 2018, opening 20 new positions and adding to 70 existing holdings. Its largest new stake was iShares MSCI EAFE Small-Cap ETF: 23,553 shares worth $1.22M.

By sector, the portfolio is most concentrated in Financials at 4.1% of assets, down from 5.2% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was UBS E-TRACS Alerian MLP Infrastructure ETN, an estimated $7.56M trimmed.

  • Aspiriant LLC's largest Q4 2018 buy was iShares MSCI EAFE Small-Cap ETF: 23,553 shares worth $1.22M.
  • Aspiriant LLC added most to iShares National Muni Bond ETF in Q4 2018, an estimated $87.8M increase.
  • Aspiriant LLC's biggest Q4 2018 reduction was UBS E-TRACS Alerian MLP Infrastructure ETN, cutting an estimated $7.56M.
  • Aspiriant LLC fully exited Brown-Forman Class B in Q4 2018, selling an estimated $702K.
  • Aspiriant LLC's ten largest holdings make up 50% of its $1.32B portfolio in Q4 2018.
  • Aspiriant LLC opened 20 new positions and closed 34 in Q4 2018.
  • Aspiriant LLC's portfolio value rose 13% quarter-over-quarter to $1.32B.

Based on Aspiriant LLC's 13F filing for Q4 2018, filed 4 Feb 2019.